APO Research
Talk to an analyst

APO RESEARCH · REPORT

PECAM-1 Antibody

Compare research editions
View pricing & licenses

Selected research

Industry Research

PECAM-1 Antibody Industry Research Report 2026

31 December 2025150 pages

Choose your research edition.

Industry ResearchPECAM-1 Antibody Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal PECAM-1 Antibody Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal PECAM-1 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PECAM-1 Antibody Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal PECAM-1 Antibody Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global PECAM-1 Antibody market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for PECAM-1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for PECAM-1 Antibody is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for PECAM-1 Antibody is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of PECAM-1 Antibody include Thermo Fisher, YO Proteins, US Biological, SICGEN, Santa Cruz Biotechnology, Rockland Immunochemicals, R&D Systems, Proteintech Group and OriGene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global PECAM-1 Antibody market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

PECAM-1 Antibody Market by Company

Thermo Fisher

YO Proteins

US Biological

SICGEN

Santa Cruz Biotechnology

Rockland Immunochemicals

R&D Systems

Proteintech Group

OriGene

Novus Biologicals

Miltenyi Biotec

MilliporeSigma

LifeSpan Biosciences

Enzo Life Sciences

Dianova

Creative Biomart

Boster

Bon Opus Biosciences

Bio-Rad

BioLegend

Abnova

Abeomics

Abcam

PECAM-1 Antibody Segment by Type

Mouse

Rabbit

Others

PECAM-1 Antibody Segment by Application

Laboratory

Hospital

Others

PECAM-1 Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PECAM-1 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PECAM-1 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PECAM-1 Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of PECAM-1 Antibody manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of PECAM-1 Antibody by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of PECAM-1 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global PECAM-1 Antibody Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global PECAM-1 Antibody Sales (Kg) of Manufacturers (2021-2026) Table 7. Global PECAM-1 Antibody Sales Market Share by Manufacturers (2021-2026) Table 8. Global PECAM-1 Antibody Revenue of Manufacturers (2021-2026) Table 9. Global PECAM-1 Antibody Revenue Share by Manufacturers (2021-2026) Table 10. Global Market PECAM-1 Antibody Average Price (US$/g) of Manufacturers (2021-2026) Table 11. Global PECAM-1 Antibody Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of PECAM-1 Antibody, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of PECAM-1 Antibody, Product Type & Application Table 14. Global PECAM-1 Antibody Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global PECAM-1 Antibody by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Thermo Fisher Company Information Table 19. Thermo Fisher Business Overview Table 20. Thermo Fisher PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 21. Thermo Fisher PECAM-1 Antibody Product Portfolio Table 22. Thermo Fisher Recent Developments Table 23. YO Proteins Company Information Table 24. YO Proteins Business Overview Table 25. YO Proteins PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 26. YO Proteins PECAM-1 Antibody Product Portfolio Table 27. YO Proteins Recent Developments Table 28. US Biological Company Information Table 29. US Biological Business Overview Table 30. US Biological PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 31. US Biological PECAM-1 Antibody Product Portfolio Table 32. US Biological Recent Developments Table 33. SICGEN Company Information Table 34. SICGEN Business Overview Table 35. SICGEN PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 36. SICGEN PECAM-1 Antibody Product Portfolio Table 37. SICGEN Recent Developments Table 38. Santa Cruz Biotechnology Company Information Table 39. Santa Cruz Biotechnology Business Overview Table 40. Santa Cruz Biotechnology PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 41. Santa Cruz Biotechnology PECAM-1 Antibody Product Portfolio Table 42. Santa Cruz Biotechnology Recent Developments Table 43. Rockland Immunochemicals Company Information Table 44. Rockland Immunochemicals Business Overview Table 45. Rockland Immunochemicals PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 46. Rockland Immunochemicals PECAM-1 Antibody Product Portfolio Table 47. Rockland Immunochemicals Recent Developments Table 48. R&D Systems Company Information Table 49. R&D Systems Business Overview Table 50. R&D Systems PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 51. R&D Systems PECAM-1 Antibody Product Portfolio Table 52. R&D Systems Recent Developments Table 53. Proteintech Group Company Information Table 54. Proteintech Group Business Overview Table 55. Proteintech Group PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 56. Proteintech Group PECAM-1 Antibody Product Portfolio Table 57. Proteintech Group Recent Developments Table 58. OriGene Company Information Table 59. OriGene Business Overview Table 60. OriGene PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 61. OriGene PECAM-1 Antibody Product Portfolio Table 62. OriGene Recent Developments Table 63. Novus Biologicals Company Information Table 64. Novus Biologicals Business Overview Table 65. Novus Biologicals PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 66. Novus Biologicals PECAM-1 Antibody Product Portfolio Table 67. Novus Biologicals Recent Developments Table 68. Miltenyi Biotec Company Information Table 69. Miltenyi Biotec Business Overview Table 70. Miltenyi Biotec PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 71. Miltenyi Biotec PECAM-1 Antibody Product Portfolio Table 72. Miltenyi Biotec Recent Developments Table 73. MilliporeSigma Company Information Table 74. MilliporeSigma Business Overview Table 75. MilliporeSigma PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 76. MilliporeSigma PECAM-1 Antibody Product Portfolio Table 77. MilliporeSigma Recent Developments Table 78. LifeSpan Biosciences Company Information Table 79. LifeSpan Biosciences Business Overview Table 80. LifeSpan Biosciences PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 81. LifeSpan Biosciences PECAM-1 Antibody Product Portfolio Table 82. LifeSpan Biosciences Recent Developments Table 83. Enzo Life Sciences Company Information Table 84. Enzo Life Sciences Business Overview Table 85. Enzo Life Sciences PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 86. Enzo Life Sciences PECAM-1 Antibody Product Portfolio Table 87. Enzo Life Sciences Recent Developments Table 88. Dianova Company Information Table 89. Dianova Business Overview Table 90. Dianova PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 91. Dianova PECAM-1 Antibody Product Portfolio Table 92. Dianova Recent Developments Table 93. Creative Biomart Company Information Table 94. Creative Biomart Business Overview Table 95. Creative Biomart PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 96. Creative Biomart PECAM-1 Antibody Product Portfolio Table 97. Creative Biomart Recent Developments Table 98. Boster Company Information Table 99. Boster Business Overview Table 100. Boster PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 101. Boster PECAM-1 Antibody Product Portfolio Table 102. Boster Recent Developments Table 103. Bon Opus Biosciences Company Information Table 104. Bon Opus Biosciences Business Overview Table 105. Bon Opus Biosciences PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 106. Bon Opus Biosciences PECAM-1 Antibody Product Portfolio Table 107. Bon Opus Biosciences Recent Developments Table 108. Bio-Rad Company Information Table 109. Bio-Rad Business Overview Table 110. Bio-Rad PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 111. Bio-Rad PECAM-1 Antibody Product Portfolio Table 112. Bio-Rad Recent Developments Table 113. BioLegend Company Information Table 114. BioLegend Business Overview Table 115. BioLegend PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 116. BioLegend PECAM-1 Antibody Product Portfolio Table 117. BioLegend Recent Developments Table 118. Abnova Company Information Table 119. Abnova Business Overview Table 120. Abnova PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 121. Abnova PECAM-1 Antibody Product Portfolio Table 122. Abnova Recent Developments Table 123. Abeomics Company Information Table 124. Abeomics Business Overview Table 125. Abeomics PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 126. Abeomics PECAM-1 Antibody Product Portfolio Table 127. Abeomics Recent Developments Table 128. Abcam Company Information Table 129. Abcam Business Overview Table 130. Abcam PECAM-1 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 131. Abcam PECAM-1 Antibody Product Portfolio Table 132. Abcam Recent Developments Table 133. Global PECAM-1 Antibody Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 134. Global PECAM-1 Antibody Sales by Region (2021-2026) & (Kg) Table 135. Global PECAM-1 Antibody Sales Market Share by Region (2021-2026) Table 136. Global PECAM-1 Antibody Sales by Region (2027-2032) & (Kg) Table 137. Global PECAM-1 Antibody Sales Market Share by Region (2027-2032) Table 138. Global PECAM-1 Antibody Revenue by Region (2021-2026) & (US$ Million) Table 139. Global PECAM-1 Antibody Revenue Market Share by Region (2021-2026) Table 140. Global PECAM-1 Antibody Revenue by Region (2027-2032) & (US$ Million) Table 141. Global PECAM-1 Antibody Revenue Market Share by Region (2027-2032) Table 142. North America PECAM-1 Antibody Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. North America PECAM-1 Antibody Sales by Country (2021-2026) & (Kg) Table 144. North America PECAM-1 Antibody Sales by Country (2027-2032) & (Kg) Table 145. North America PECAM-1 Antibody Revenue by Country (2021-2026) & (US$ Million) Table 146. North America PECAM-1 Antibody Revenue by Country (2027-2032) & (US$ Million) Table 147. Europe PECAM-1 Antibody Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Europe PECAM-1 Antibody Sales by Country (2021-2026) & (Kg) Table 149. Europe PECAM-1 Antibody Sales by Country (2027-2032) & (Kg) Table 150. Europe PECAM-1 Antibody Revenue by Country (2021-2026) & (US$ Million) Table 151. Europe PECAM-1 Antibody Revenue by Country (2027-2032) & (US$ Million) Table 152. Asia Pacific PECAM-1 Antibody Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Asia Pacific PECAM-1 Antibody Sales by Country (2021-2026) & (Kg) Table 154. Asia Pacific PECAM-1 Antibody Sales by Country (2027-2032) & (Kg) Table 155. Asia Pacific PECAM-1 Antibody Revenue by Country (2021-2026) & (US$ Million) Table 156. Asia Pacific PECAM-1 Antibody Revenue by Country (2027-2032) & (US$ Million) Table 157. South America PECAM-1 Antibody Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. South America PECAM-1 Antibody Sales by Country (2021-2026) & (Kg) Table 159. South America PECAM-1 Antibody Sales by Country (2027-2032) & (Kg) Table 160. South America PECAM-1 Antibody Revenue by Country (2021-2026) & (US$ Million) Table 161. South America PECAM-1 Antibody Revenue by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa PECAM-1 Antibody Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Middle East and Africa PECAM-1 Antibody Sales by Country (2021-2026) & (Kg) Table 164. Middle East and Africa PECAM-1 Antibody Sales by Country (2027-2032) & (Kg) Table 165. Middle East and Africa PECAM-1 Antibody Revenue by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa PECAM-1 Antibody Revenue by Country (2027-2032) & (US$ Million) Table 167. Global PECAM-1 Antibody Sales by Type (2021-2026) & (Kg) Table 168. Global PECAM-1 Antibody Sales by Type (2027-2032) & (Kg) Table 169. Global PECAM-1 Antibody Sales Market Share by Type (2021-2026) Table 170. Global PECAM-1 Antibody Sales Market Share by Type (2027-2032) Table 171. Global PECAM-1 Antibody Revenue by Type (2021-2026) & (US$ Million) Table 172. Global PECAM-1 Antibody Revenue by Type (2027-2032) & (US$ Million) Table 173. Global PECAM-1 Antibody Revenue Market Share by Type (2021-2026) Table 174. Global PECAM-1 Antibody Revenue Market Share by Type (2027-2032) Table 175. Global PECAM-1 Antibody Price by Type (2021-2026) & (US$/g) Table 176. Global PECAM-1 Antibody Price by Type (2027-2032) & (US$/g) Table 177. Global PECAM-1 Antibody Sales by Application (2021-2026) & (Kg) Table 178. Global PECAM-1 Antibody Sales by Application (2027-2032) & (Kg) Table 179. Global PECAM-1 Antibody Sales Market Share by Application (2021-2026) Table 180. Global PECAM-1 Antibody Sales Market Share by Application (2027-2032) Table 181. Global PECAM-1 Antibody Revenue by Application (2021-2026) & (US$ Million) Table 182. Global PECAM-1 Antibody Revenue by Application (2027-2032) & (US$ Million) Table 183. Global PECAM-1 Antibody Revenue Market Share by Application (2021-2026) Table 184. Global PECAM-1 Antibody Revenue Market Share by Application (2027-2032) Table 185. Global PECAM-1 Antibody Price by Application (2021-2026) & (US$/g) Table 186. Global PECAM-1 Antibody Price by Application (2027-2032) & (US$/g) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. PECAM-1 Antibody Distributors List Table 190. PECAM-1 Antibody Customers List Table 191. PECAM-1 Antibody Industry Trends Table 192. PECAM-1 Antibody Industry Drivers Table 193. PECAM-1 Antibody Industry Restraints Table 194. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. PECAM-1 Antibody Product Image Figure 5. Global PECAM-1 Antibody Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global PECAM-1 Antibody Market Size (2021-2032) & (US$ Million) Figure 7. Global PECAM-1 Antibody Sales (2021-2032) & (Kg) Figure 8. Global PECAM-1 Antibody Average Price (US$/g) & (2021-2032) Figure 9. Mouse Product Image Figure 10. Rabbit Product Image Figure 11. Others Product Image Figure 12. Laboratory Product Image Figure 13. Hospital Product Image Figure 14. Others Product Image Figure 15. Global PECAM-1 Antibody Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of PECAM-1 Antibody, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 PECAM-1 Antibody Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global PECAM-1 Antibody Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global PECAM-1 Antibody Sales by Region in 2025 Figure 21. Global PECAM-1 Antibody Revenue by Region in 2025 Figure 22. North America PECAM-1 Antibody Market Size by Country in 2025 Figure 23. North America PECAM-1 Antibody Sales Market Share by Country (2021-2032) Figure 24. North America PECAM-1 Antibody Revenue Market Share by Country (2021-2032) Figure 25. United States PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe PECAM-1 Antibody Market Size by Country in 2025 Figure 28. Europe PECAM-1 Antibody Sales Market Share by Country (2021-2032) Figure 29. Europe PECAM-1 Antibody Revenue Market Share by Country (2021-2032) Figure 30. Germany PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Asia Pacific PECAM-1 Antibody Market Size by Country in 2025 Figure 36. Asia Pacific PECAM-1 Antibody Sales Market Share by Country (2021-2032) Figure 37. Asia Pacific PECAM-1 Antibody Revenue Market Share by Country (2021-2032) Figure 38. China PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Japan PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. South Korea PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. India PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Australia PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. China Taiwan PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South America PECAM-1 Antibody Market Size by Country in 2025 Figure 47. South America PECAM-1 Antibody Sales Market Share by Country (2021-2032) Figure 48. South America PECAM-1 Antibody Revenue Market Share by Country (2021-2032) Figure 49. Mexico PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Brazil PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Argentina PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Middle East and Africa PECAM-1 Antibody Market Size by Country in 2025 Figure 53. Middle East and Africa PECAM-1 Antibody Sales Market Share by Country (2021-2032) Figure 54. Middle East and Africa PECAM-1 Antibody Revenue Market Share by Country (2021-2032) Figure 55. Turkey PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Saudi Arabia PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. UAE PECAM-1 Antibody Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Global PECAM-1 Antibody Sales Market Share by Type (2021-2032) Figure 59. Global PECAM-1 Antibody Revenue Market Share by Type (2021-2032) Figure 60. Global PECAM-1 Antibody Price (US$/g) by Type (2021-2032) Figure 61. Global PECAM-1 Antibody Sales Market Share by Application (2021-2032) Figure 62. Global PECAM-1 Antibody Revenue Market Share by Application (2021-2032) Figure 63. Global PECAM-1 Antibody Price (US$/g) by Application (2021-2032) Figure 64. PECAM-1 Antibody Value Chain Figure 65. PECAM-1 Antibody Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. PECAM-1 Antibody Industry Opportunities and Challenges

Scope & coverage.

Types
  • Mouse
  • Rabbit
  • Others
Applications
  • Laboratory
  • Hospital
  • Others
Companies covered
  • Thermo Fisher
  • YO Proteins
  • US Biological
  • SICGEN
  • Santa Cruz Biotechnology
  • Rockland Immunochemicals
  • R&D Systems
  • Proteintech Group
  • OriGene
  • Novus Biologicals
  • Miltenyi Biotec
  • MilliporeSigma
  • LifeSpan Biosciences
  • Enzo Life Sciences
  • Dianova
  • Creative Biomart
  • Boster
  • Bon Opus Biosciences
  • Bio-Rad
  • BioLegend
  • Abnova
  • Abeomics
  • Abcam

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global PECAM-1 Antibody Market Size (2021-2032)
  4. 2.2.2 Global PECAM-1 Antibody Sales (2021-2032)
  5. 2.2.3 Global PECAM-1 Antibody Market Average Price (2021-2032)
  6. 2.3 PECAM-1 Antibody by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Mouse
  9. 2.3.3 Rabbit
  10. 2.3.4 Others
  11. 2.4 PECAM-1 Antibody by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Laboratory
  14. 2.4.3 Hospital
  15. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global PECAM-1 Antibody Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global PECAM-1 Antibody Sales (Kg) of Manufacturers (2021-2026)
  3. 3.3 Global PECAM-1 Antibody Revenue of Manufacturers (2021-2026)
  4. 3.4 Global PECAM-1 Antibody Average Price by Manufacturers (2021-2026)
  5. 3.5 Global PECAM-1 Antibody Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of PECAM-1 Antibody, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of PECAM-1 Antibody, Product Type & Application
  8. 3.8 Global Manufacturers of PECAM-1 Antibody, Established Date
  9. 3.9 Global PECAM-1 Antibody Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Thermo Fisher
  2. 4.1.1 Thermo Fisher Company Information
  3. 4.1.2 Thermo Fisher Business Overview
  4. 4.1.3 Thermo Fisher PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Thermo Fisher PECAM-1 Antibody Product Portfolio
  6. 4.1.5 Thermo Fisher Recent Developments
  7. 4.2 YO Proteins
  8. 4.2.1 YO Proteins Company Information
  9. 4.2.2 YO Proteins Business Overview
  10. 4.2.3 YO Proteins PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 YO Proteins PECAM-1 Antibody Product Portfolio
  12. 4.2.5 YO Proteins Recent Developments
  13. 4.3 US Biological
  14. 4.3.1 US Biological Company Information
  15. 4.3.2 US Biological Business Overview
  16. 4.3.3 US Biological PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 US Biological PECAM-1 Antibody Product Portfolio
  18. 4.3.5 US Biological Recent Developments
  19. 4.4 SICGEN
  20. 4.4.1 SICGEN Company Information
  21. 4.4.2 SICGEN Business Overview
  22. 4.4.3 SICGEN PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 SICGEN PECAM-1 Antibody Product Portfolio
  24. 4.4.5 SICGEN Recent Developments
  25. 4.5 Santa Cruz Biotechnology
  26. 4.5.1 Santa Cruz Biotechnology Company Information
  27. 4.5.2 Santa Cruz Biotechnology Business Overview
  28. 4.5.3 Santa Cruz Biotechnology PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Santa Cruz Biotechnology PECAM-1 Antibody Product Portfolio
  30. 4.5.5 Santa Cruz Biotechnology Recent Developments
  31. 4.6 Rockland Immunochemicals
  32. 4.6.1 Rockland Immunochemicals Company Information
  33. 4.6.2 Rockland Immunochemicals Business Overview
  34. 4.6.3 Rockland Immunochemicals PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Rockland Immunochemicals PECAM-1 Antibody Product Portfolio
  36. 4.6.5 Rockland Immunochemicals Recent Developments
  37. 4.7 R&D Systems
  38. 4.7.1 R&D Systems Company Information
  39. 4.7.2 R&D Systems Business Overview
  40. 4.7.3 R&D Systems PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 R&D Systems PECAM-1 Antibody Product Portfolio
  42. 4.7.5 R&D Systems Recent Developments
  43. 4.8 Proteintech Group
  44. 4.8.1 Proteintech Group Company Information
  45. 4.8.2 Proteintech Group Business Overview
  46. 4.8.3 Proteintech Group PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Proteintech Group PECAM-1 Antibody Product Portfolio
  48. 4.8.5 Proteintech Group Recent Developments
  49. 4.9 OriGene
  50. 4.9.1 OriGene Company Information
  51. 4.9.2 OriGene Business Overview
  52. 4.9.3 OriGene PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 OriGene PECAM-1 Antibody Product Portfolio
  54. 4.9.5 OriGene Recent Developments
  55. 4.10 Novus Biologicals
  56. 4.10.1 Novus Biologicals Company Information
  57. 4.10.2 Novus Biologicals Business Overview
  58. 4.10.3 Novus Biologicals PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Novus Biologicals PECAM-1 Antibody Product Portfolio
  60. 4.10.5 Novus Biologicals Recent Developments
  61. 4.11 Miltenyi Biotec
  62. 4.11.1 Miltenyi Biotec Company Information
  63. 4.11.2 Miltenyi Biotec Business Overview
  64. 4.11.3 Miltenyi Biotec PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Miltenyi Biotec PECAM-1 Antibody Product Portfolio
  66. 4.11.5 Miltenyi Biotec Recent Developments
  67. 4.12 MilliporeSigma
  68. 4.12.1 MilliporeSigma Company Information
  69. 4.12.2 MilliporeSigma Business Overview
  70. 4.12.3 MilliporeSigma PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 MilliporeSigma PECAM-1 Antibody Product Portfolio
  72. 4.12.5 MilliporeSigma Recent Developments
  73. 4.13 LifeSpan Biosciences
  74. 4.13.1 LifeSpan Biosciences Company Information
  75. 4.13.2 LifeSpan Biosciences Business Overview
  76. 4.13.3 LifeSpan Biosciences PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 LifeSpan Biosciences PECAM-1 Antibody Product Portfolio
  78. 4.13.5 LifeSpan Biosciences Recent Developments
  79. 4.14 Enzo Life Sciences
  80. 4.14.1 Enzo Life Sciences Company Information
  81. 4.14.2 Enzo Life Sciences Business Overview
  82. 4.14.3 Enzo Life Sciences PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Enzo Life Sciences PECAM-1 Antibody Product Portfolio
  84. 4.14.5 Enzo Life Sciences Recent Developments
  85. 4.15 Dianova
  86. 4.15.1 Dianova Company Information
  87. 4.15.2 Dianova Business Overview
  88. 4.15.3 Dianova PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Dianova PECAM-1 Antibody Product Portfolio
  90. 4.15.5 Dianova Recent Developments
  91. 4.16 Creative Biomart
  92. 4.16.1 Creative Biomart Company Information
  93. 4.16.2 Creative Biomart Business Overview
  94. 4.16.3 Creative Biomart PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Creative Biomart PECAM-1 Antibody Product Portfolio
  96. 4.16.5 Creative Biomart Recent Developments
  97. 4.17 Boster
  98. 4.17.1 Boster Company Information
  99. 4.17.2 Boster Business Overview
  100. 4.17.3 Boster PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Boster PECAM-1 Antibody Product Portfolio
  102. 4.17.5 Boster Recent Developments
  103. 4.18 Bon Opus Biosciences
  104. 4.18.1 Bon Opus Biosciences Company Information
  105. 4.18.2 Bon Opus Biosciences Business Overview
  106. 4.18.3 Bon Opus Biosciences PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Bon Opus Biosciences PECAM-1 Antibody Product Portfolio
  108. 4.18.5 Bon Opus Biosciences Recent Developments
  109. 4.19 Bio-Rad
  110. 4.19.1 Bio-Rad Company Information
  111. 4.19.2 Bio-Rad Business Overview
  112. 4.19.3 Bio-Rad PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Bio-Rad PECAM-1 Antibody Product Portfolio
  114. 4.19.5 Bio-Rad Recent Developments
  115. 4.20 BioLegend
  116. 4.20.1 BioLegend Company Information
  117. 4.20.2 BioLegend Business Overview
  118. 4.20.3 BioLegend PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 BioLegend PECAM-1 Antibody Product Portfolio
  120. 4.20.5 BioLegend Recent Developments
  121. 4.21 Abnova
  122. 4.21.1 Abnova Company Information
  123. 4.21.2 Abnova Business Overview
  124. 4.21.3 Abnova PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Abnova PECAM-1 Antibody Product Portfolio
  126. 4.21.5 Abnova Recent Developments
  127. 4.22 Abeomics
  128. 4.22.1 Abeomics Company Information
  129. 4.22.2 Abeomics Business Overview
  130. 4.22.3 Abeomics PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Abeomics PECAM-1 Antibody Product Portfolio
  132. 4.22.5 Abeomics Recent Developments
  133. 4.23 Abcam
  134. 4.23.1 Abcam Company Information
  135. 4.23.2 Abcam Business Overview
  136. 4.23.3 Abcam PECAM-1 Antibody Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Abcam PECAM-1 Antibody Product Portfolio
  138. 4.23.5 Abcam Recent Developments
5 Global PECAM-1 Antibody Market Scenario by Region
  1. 5.1 Global PECAM-1 Antibody Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global PECAM-1 Antibody Sales by Region: 2021-2032
  3. 5.2.1 Global PECAM-1 Antibody Sales by Region: 2021-2026
  4. 5.2.2 Global PECAM-1 Antibody Sales by Region: 2027-2032
  5. 5.3 Global PECAM-1 Antibody Revenue by Region: 2021-2032
  6. 5.3.1 Global PECAM-1 Antibody Revenue by Region: 2021-2026
  7. 5.3.2 Global PECAM-1 Antibody Revenue by Region: 2027-2032
  8. 5.4 North America PECAM-1 Antibody Market Facts & Figures by Country
  9. 5.4.1 North America PECAM-1 Antibody Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America PECAM-1 Antibody Sales by Country (2021-2032)
  11. 5.4.3 North America PECAM-1 Antibody Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe PECAM-1 Antibody Market Facts & Figures by Country
  15. 5.5.1 Europe PECAM-1 Antibody Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe PECAM-1 Antibody Sales by Country (2021-2032)
  17. 5.5.3 Europe PECAM-1 Antibody Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific PECAM-1 Antibody Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific PECAM-1 Antibody Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific PECAM-1 Antibody Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific PECAM-1 Antibody Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America PECAM-1 Antibody Market Facts & Figures by Country
  35. 5.7.1 South America PECAM-1 Antibody Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America PECAM-1 Antibody Sales by Country (2021-2032)
  37. 5.7.3 South America PECAM-1 Antibody Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa PECAM-1 Antibody Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa PECAM-1 Antibody Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa PECAM-1 Antibody Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa PECAM-1 Antibody Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global PECAM-1 Antibody Sales by Type (2021-2032)
  2. 6.1.1 Global PECAM-1 Antibody Sales by Type (2021-2032) & (Kg)
  3. 6.1.2 Global PECAM-1 Antibody Sales Market Share by Type (2021-2032)
  4. 6.2 Global PECAM-1 Antibody Revenue by Type (2021-2032)
  5. 6.2.1 Global PECAM-1 Antibody Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global PECAM-1 Antibody Revenue Market Share by Type (2021-2032)
  7. 6.3 Global PECAM-1 Antibody Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global PECAM-1 Antibody Sales by Application (2021-2032)
  2. 7.1.1 Global PECAM-1 Antibody Sales by Application (2021-2032) & (Kg)
  3. 7.1.2 Global PECAM-1 Antibody Sales Market Share by Application (2021-2032)
  4. 7.2 Global PECAM-1 Antibody Revenue by Application (2021-2032)
  5. 7.2.1 Global PECAM-1 Antibody Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global PECAM-1 Antibody Revenue Market Share by Application (2021-2032)
  7. 7.3 Global PECAM-1 Antibody Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 PECAM-1 Antibody Value Chain Analysis
  2. 8.1.1 PECAM-1 Antibody Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 PECAM-1 Antibody Production Mode & Process
  5. 8.2 PECAM-1 Antibody Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 PECAM-1 Antibody Distributors
  8. 8.2.3 PECAM-1 Antibody Customers
9 Global PECAM-1 Antibody Analyzing Market Dynamics
  1. 9.1 PECAM-1 Antibody Industry Trends
  2. 9.2 PECAM-1 Antibody Industry Drivers
  3. 9.3 PECAM-1 Antibody Industry Opportunities and Challenges
  4. 9.4 PECAM-1 Antibody Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst